Basit öğe kaydını göster

What is the role of whole brain radiation therapy (WBRT) and high-dose cytarabine (Ara-C) as consolidation treatment after initial chemotherapy for primary CNS lymphoma (PCNSL)?

dc.contributor.authorYAHALOM, J.
dc.contributor.authorEkenel, MELTEM
dc.contributor.authorPANAGEAS, K. S.
dc.contributor.authorDEANGELIS, L. M.
dc.contributor.authorABREY, L. E.
dc.contributor.authorIWAMOTO, F. M.
dc.contributor.authorBEN PORAT, L. S.
dc.date.accessioned2021-03-05T12:25:27Z
dc.date.available2021-03-05T12:25:27Z
dc.date.issued2007
dc.identifier.citationEkenel M., IWAMOTO F. M. , BEN PORAT L. S. , PANAGEAS K. S. , YAHALOM J., DEANGELIS L. M. , ABREY L. E. , "What is the role of whole brain radiation therapy (WBRT) and high-dose cytarabine (Ara-C) as consolidation treatment after initial chemotherapy for primary CNS lymphoma (PCNSL)?", JOURNAL OF CLINICAL ONCOLOGY, cilt.25, 2007
dc.identifier.issn0732-183X
dc.identifier.othervv_1032021
dc.identifier.otherav_ad1bdf60-5de4-402e-be25-8054069965a4
dc.identifier.urihttp://hdl.handle.net/20.500.12627/115508
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleWhat is the role of whole brain radiation therapy (WBRT) and high-dose cytarabine (Ara-C) as consolidation treatment after initial chemotherapy for primary CNS lymphoma (PCNSL)?
dc.typeMakale
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGY
dc.contributor.departmentMemorial Sloan Kettering Cancer Center , ,
dc.identifier.volume25
dc.identifier.issue18
dc.contributor.firstauthorID89095


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster